Costa Rica vs Paraguay: HIV/AIDS deaths averted by antiretroviral therapy
Costa Rica
747.26 deaths
in 2024
Paraguay
748.25 deaths
in 2024
Costa Rica rank
83rd
Paraguay rank
82nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Costa Rica
- Paraguay
How they compare
Paraguay currently reports 748.25 deaths against 747.26 deaths in Costa Rica, a difference of 0.99 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Paraguay ahead.
Costa Rica ranks 83rd and Paraguay ranks 82nd of 157 countries.
Across the 4 decades both report, Costa Rica averaged higher in 1 and Paraguay in 2.
Head to head by decade
| Decade | Costa Rica | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 162.78 deaths | 104.86 deaths | 57.92 deaths | Costa Rica |
| 2010s | 432.26 deaths | 475.81 deaths | 43.56 deaths | Paraguay |
| 2020s | 675.17 deaths | 692.4 deaths | 17.23 deaths | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Costa Rica or Paraguay?
- Paraguay, at 748.25 deaths against 747.26 deaths in Costa Rica as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Costa Rica and Paraguay?
- 0.99 deaths, with Paraguay ahead.
- How many years of comparable data are there for Costa Rica and Paraguay?
- 35 years are reported by both, from 1990 to 2024.
- How do Costa Rica and Paraguay rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Costa Rica ranks 83rd and Paraguay ranks 82nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.